Jeanet Ter Huurne
Overview
Explore the profile of Jeanet Ter Huurne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nik Mohd Hasan N, Arkesteijn S, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, Schaap R, et al.
Int J Lab Hematol
. 2024 Oct;
47(2):326-329.
PMID: 39380484
No abstract available.
2.
Harteveld C, Achour A, Fairuz Mohd Hasan N, Legebeke J, Arkesteijn S, Ter Huurne J, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201615
It is well known that modifiers play a role in ameliorating or exacerbating disease phenotypes in patients and carriers of recessively inherited disorders such as sickle cell disease and thalassemia....
3.
Harteveld C, Achour A, Arkesteijn S, Ter Huurne J, Verschuren M, Bhagwandien-Bisoen S, et al.
Int J Lab Hematol
. 2022 Sep;
44 Suppl 1:28-36.
PMID: 36074711
Hemoglobinopathies are the most common monogenic disorders in the world with an ever increasing global disease burden each year. As most hemoglobinopathies show recessive inheritance carriers are usually clinically silent....
4.
Achour A, Koopmann T, Castel R, Santen G, den Hollander N, Knijnenburg J, et al.
Blood
. 2020 Jun;
136(15):1789-1793.
PMID: 32589702
No abstract available.
5.
Achour A, de Grouw E, van Erp F, Arkesteijn S, Schaap R, Ter Huurne J, et al.
Int J Lab Hematol
. 2019 Jan;
41(3):e76-e78.
PMID: 30663218
No abstract available.
6.
Paleari R, Ceriotti F, Harteveld C, Strollo M, Bakker-Verweij G, Ter Huurne J, et al.
Clin Chim Acta
. 2017 Dec;
477:60-65.
PMID: 29203428
Background: Most of the current methods used for the determination of HbA seem not well aligned. A comparison among the best performing techniques and the commutability of some control materials...
7.
Harland M, Goldstein A, Kukalizch K, Taylor C, Hogg D, Puig S, et al.
Eur J Cancer
. 2008 Apr;
44(9):1269-74.
PMID: 18394881
CDKN2A is the major melanoma susceptibility gene so far identified, but only 40% of three or more case families have identified mutations. A comparison of mutation detection rates was carried...